YBX1 and breast carcinoma: YB-1 protects breast cancer cells from apoptosis via activation of AKT/mTOR and phosphorylation of STAT3 at serine 727 [31] and in renal cancer YB1 stabilizes STAT3 and YB-1/STAT3 signaling mediate resistance to interferon a therapy [32].